Evonik current strategy chief be next CEO

Evonik current strategy chief to be next CEO: Sources

11:02 AM, 28th February 2017
Christian Kullmann
Christian Kullmann, deputy chairman of the executive board of Evonik will take over as the CEO. (File photo)

FRANKFURT, GERMANY: Evonik Industries's current chief strategic officer, Christian Kullmann will take over as the company’s new CEO in May, succeeding current chief executive officer (CEO) Klaus Engel, who is stepping down early.

Evonik said that the departure of 60-year-old Engel, highlighted by Reuters was amicable but did not provide details on why he was leaving.

Kullmann (47) joined the management board of Evonik in 2014 and became deputy CEO in May 2016, announcing his ascension to the top job. He was involved in key takeovers, including Evonik's $630 million purchase of J M Huber Corp’s silica unit in December, sources said.

He will be replaced as deputy CEO by Harald Schwager, currently responsible for chemistry and innovation, effective from 1 September, Evonik said.

Chief operating officer Ralph Sven Kaufmann is also stepping down early and will not be replaced, Evonik said, shrinking its management board to four members. It said it expected its supervisory board to take a final decision on the management reshuffle on 1 March.

© Reuters News 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


New clues found for better nuclear waste cleanup

PULLMAN, US: A recent study of the chemistry of technetium-99 from Washington State University (WSU) has improved the understanding of the challenging ...

Read more
A Schulman to open distribution centre in US

AKRON, US: A Schulman Inc said that it will open a distribution centre at its Stryker, Ohio plant to serve customers located in Indiana ...

Read more
New technology offers fast peptide synthesis

MASSACHUSETTS, US: Manufacturing small proteins known as peptides is usually very time-consuming, which has slowed development of new peptide drugs fo ...

Read more
Lonza, Sanofi to build Swiss biologics facility; invests €270 mn

BASEL, SWITZERLAND/ PARIS, FRANCE: Lonza Group and Sanofi SA have entered into a strategic partnership to build and operate a large-scale mammali ...

Read more
Fluor bags maintenance contract by SunCoke Energy

IRVING, US: Fluor Corporation has been awarded a maintenance support and capital project services contract by SunCoke Energy Inc, for its coke facilit ...

Read more
New research advances energy savings for oil, gas industries

PULLMAN, US: A research team from Washington State University (WSU) has improved an important catalytic reaction commonly used in the oil and gas indu ...

Read more